Pro Medicus Limited (PMCUF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:38PM EDT
| Previous close | 69.25 |
| Open | 68.34 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 69.25 - 69.25 |
| 52-week range | 38.19 - 73.04 |
| Volume | |
| Avg. volume | 179 |
| Market cap | 7.312B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 161.05 |
| EPS (TTM) | 0.43 |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.34%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
Simply Wall St.Pro Medicus' (ASX:PME) 45% CAGR outpaced the company's earnings growth over the same five-year period
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...
- Simply Wall St.
Despite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 51% interest
Key Insights Significant insider control over Pro Medicus implies vested interests in company growth 50% of the...
PR NewswireVisage Launches Visage Ease VP™ for Apple Vision Pro
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the launch of the groundbreaking Visage Ease VP for Apple Vision Pro, Apple's highly anticipated spatial computing platform released today.
© 2024 Yahoo. All rights reserved.